SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
由于抗病毒免疫反应受损，患有炎症性自身免疫性疾病或接受霉酚酸酯治疗的肝移植患者接种疫苗后，SARS-CoV-2 感染风险更高：RIVALSA 前瞻性队列的长期随访结果
期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2023.1185278
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, Erika Zecca, Erica Matino, Micol Cittone, Eleonora Rizzi, Giuseppe Francesco Casciaro, Davide D'Onghia, Donato Colangelo, Rosalba Minisini, Mattia Bellan, Luigi Mario Castello, Annalisa Chiocchetti, Mario Pirisi, Cristina Rigamonti, Daniele Lilleri,
